(AGENPARL) – SILVER SPRING gio 06 aprile 2023 Information about the mission and objectives of FDA’s Drug Development Tool (DDT) qualification…
Browsing: salute
(AGENPARL) – gio 06 aprile 2023 No images? [Click here](https://worldhealthorganization.cmail19.com/t/d-e-zkigiy-iitylyihjr-jh/) [Subscribe to receive this weekly update](https://worldhealthorganization.cmail19.com/t/d-l-zkigiy-iitylyihjr-r/) Community health worker Maryam…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 La FDA actualiza la información sobre los reportes de carcinoma de células escamosas…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 The recall, which began in October 2018, was originally initiated due to a…
(AGENPARL) – HOUSTON gio 06 aprile 2023 By Bryan Luhn — New research conducted by the University of Houston Conrad…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 Quinacrine appears on the FDA 503B list of bulk drug substances that may…
(AGENPARL) – gio 06 aprile 2023 Motivo della segnalazione: Rischio chimico Data di ricezione: 06/04/2023 Fonte/Source: https://www.salute.gov.it/portale/news/p3_2_1_3_5_1.jsp?lingua=italiano&menu=notizie&p=avvisi&tipo=richiami&id=2124
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 The Food and Drug Administration (FDA) fosters partnerships with counterpart foreign government agencies…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 FDA CDER proposed that Makena (hydroxyprogesterone caproate injection) be withdrawn from the market…
(AGENPARL) – SILVER SPRING gio 06 aprile 2023 Today, the FDA announced the final decision to withdraw approval of Makena—a drug…